Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Pembrolizumab
Radiotherapy
Locations
1
United States
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
January 8, 2015
Primary Completion Date
December 1, 2018
Completion Date
December 31, 2019
Last Updated
May 12, 2021
NCT07236021
NCT04958434
NCT01723306
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions